Treatment Sequencing Patterns in Patients with Metastatic Urothelial Cancer Treated in the Community Practice Setting in the United States: SPEAR-Bladder (Study informing treatment Pathway dEcision in bladder cAnceR)

ClinicoEconomics and Outcomes Research : CEOR
Gurjyot K DoshiHemant Phatak

Abstract

Clinical trial evidence has affirmed the role for immuno-oncology (IO) treatment for locally advanced or metastatic urothelial carcinoma (la/mUC). This Study informing treatment Pathway dEcision in bladder cAnceR (SPEAR-Bladder) aimed to provide insight into the optimal sequencing of IO treatments among la/mUC patients treated in the US Oncology Network. This was a retrospective analysis of adult patients with la/mUC who initiated first-line chemotherapy followed by either IO therapy (C-IO subgroup) or chemotherapy (C-C subgroup) between 01/01/2015 and 04/30/2017 and included a potential follow-up period through 06/30/2017. Data were sourced from iKnowMed electronic health records. Patient and treatment characteristics were assessed descriptively, with Kaplan-Meier methods used to evaluate time-to-event outcomes, including overall survival (OS). A total of 117 patients were included in this analysis (median age 69 years, 74.4% male, 88.0% Caucasian): 79 and 38 patients were in the C-IO and C-C subgroups, respectively. The median OS was 19.2 months among patients who received the C-IO sequence and 11.9 months among those who received the C-C treatment sequence. These results suggest that patients who received the C-IO treatment ...Continue Reading

References

Jul 22, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hans von der MaaseMichael Arning
Aug 19, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joaquim BellmuntHans von der Maase
Jan 21, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J BellmuntS Signoretti
Jan 22, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael A PostowJedd D Wolchok
Apr 4, 2015·Hematology/oncology Clinics of North America·Sujata NarayananSandy Srinivas
Jul 7, 2018·TheScientificWorldJournal·Nedal BukhariFaisal Azam
Sep 6, 2018·Investigative and Clinical Urology·Hyung Suk Kim, Ho Kyung Seo
Sep 13, 2018·Clinical Genitourinary Cancer·Maxine D FisherMark S Walker
Apr 10, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthew D GalskySumanta K Pal
Sep 19, 2020·The New England Journal of Medicine·Thomas PowlesPetros Grivas

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Clinical Trials Mentioned

NCT02603432
NCT02500121

Software Mentioned

Bladder
iKM
iKnowMed
SPEAR

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Healthcare Informatics : the Business Magazine for Information and Communication Systems
Steve Garske
Injury
Mario Randelli, Giorgio Maria Calori
Healthcare Financial Management : Journal of the Healthcare Financial Management Association
John P Glaser
Health Management Technology
Andy Crowder
© 2021 Meta ULC. All rights reserved